China Plant Sterol Trial
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00145717|
Recruitment Status : Completed
First Posted : September 5, 2005
Last Update Posted : September 5, 2005
|Condition or disease||Intervention/treatment||Phase|
|Hypercholesterolemia Cardiovascular Diseases||Drug: Plant sterol enriched milk tea||Phase 3|
RESEARCH PLAN The study is a randomised, double-blind, placebo-controlled trial with three parallel groups, two assigned different doses of active treatment and one assigned placebo. The total study period for participants will be an average of seven weeks comprised of a two-week placebo treatment run-in period prior to randomisation and a five-week follow-up on randomised treatment. An estimated 400 participants will be commenced on run-in with the expectation that 300 (100 in each group) will go on to randomisation.
STUDY TREATMENTS Pre-randomisation open run-in phase: All potentially eligible participants will commence a 10-20 days run-in period with the placebo milk tea administered twice daily. This run-in period will help to identify before randomisation, those individuals who are unlikely to tolerate the milk tea product or comply with the study follow up procedures.
Post randomisation double-blind treatment phase: Participants that successfully complete the run-in phase will be assigned at random to receive either:
- Milk tea containing a total of 2.3g of plant sterol each day administered in two divided doses of 1.15g; or
- Milk tea containing a total of 1.5g of plant sterol each day administered in two divided doses of 0.75g; or
- Placebo milk tea containing no plant sterol. Blinding of participants and investigators will be assured by providing all groups with their allocated treatment in packaging that is identical except for a unique identifying number corresponding to the randomisation code.
- 2.3g/d treatment group compared to placebo group
- 1.5g/d treatment group compared to placebo group
- active treatment group (2.3g/d and 1.5g/d combined) compared to placebo group
- 2.3g/d treatment group compared to 1.5g/d treatment group
- Secondary: To establish the effects of the same intervention on total cholesterol levels.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||300 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||China Plant Sterol Trial - A Randomised Trial to Determine the Effects on Blood Cholesterol Levels of a Milk Tea Product Enriched With Plant Sterol Among 300 Chinese Living in Beijing|
|Study Start Date :||April 2005|
|Study Completion Date :||July 2005|
- Low density lipoprotein cholesterol levels
- Total cholesterol levels;
- High density lipoprotein cholesterol levels;
- Triglycerides levels;
- Liking and adherence
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00145717
|Peking University Health Science Centre|
|Beijing, China, 100083|
|Principal Investigator:||Bruce C Neal, MRCP, PhD||The George Institute|